High Expression of Tetraspanin 5 as a Prognostic Marker of Colorectal Cancer
International Journal of Molecular Sciences · 30.03.2023 · 24 (7) · 6476
DOI: 10.3390/ijms24076476 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.03.2023. Verfasst von Sanghyun Roh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Medicine, Soonchunhyang University, 31 Soonchunhyang 6 gil, Dongnam-gu, Cheonan 31151, Chungcheongnam-do, Republi…. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), Ministry of Education, Soonchunhyang University Research Fund.
Abstract (Originalsprache)
Cancer is a major disease and the leading cause of death worldwide, with colorectal cancer (CRC) being the third-most common cancer in Korea. The survival rate associated with CRC reduces as the disease stage increases. Therefore, its early detection and treatment can greatly increase patient survival rates. In this study, we identified the tetraspanin 5 (TSPAN5) gene as an important biomarker for predicting the prognosis of patients with CRC. A TMA slide was used for statistical analysis. pN and clinical stage were found to be significant factors according to chi-square analysis, whereas pT, pN, metastasis, clinical stage, and TSPAN5 expression were significant according to Cox regression analysis. In order to prove the usefulness of TSPAN5, which is overexpressed in patients with metastatic CRC, as a biomarker, proliferation, migration, invasion, and tumorigenicity were examined using cell lines inhibited using small interfering RNA. The evaluations confirmed that TSPAN5 suppression, in turn, suppressed proliferation, migration, invasion, and tumorigenesis, which are characteristic of cancer cells. Therefore, the evaluation of TSPAN5 expression may help observe the prognosis of CRC and determine an appropriate treatment method for patients with CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, College of Medicine, Soonchunhyang University, 31 Soonchunhyang 6 gil, Dongnam-gu, Cheonan 31151, Chungcheongnam-do, Republic of Korea.
- Department of Oncology, College of Medicine, Soonchunhyang University, 31 Soonchunhyang 6 gil, Dongnam-gu, Cheonan 31151, Chungcheongnam-do, Republic of Korea.
- Department of Surgery, College of Medicine, Soonchunhyang University, 31 Soonchunhyang 6 gil, Dongnam-gu, Cheonan 31151, Chungcheongnam-do, Republic of Korea.
- Research Institute of Clinical Medicine, Woori Madi Medical Center, 111 Baekjedae-ro, Wansan-gu, Jeonju 55082, Jeollabuk-do, Republic of Korea.
ORCID-Profile: Sanghyun Roh, Dongjun Jeong
Förderung
- National Research Foundation of Korea (NRF)
- Ministry of Education
- Soonchunhyang University Research Fund
Zitieren
APA
Roh, S., Kim, S., Hong, I., Lee, M., Kim, H. J., Ahn, T. S., Kang, D. H., Baek, M. J., Kwak, H. J., Kim, C. J., & Jeong, D. (2023). High Expression of Tetraspanin 5 as a Prognostic Marker of Colorectal Cancer. International Journal of Molecular Sciences, 24(7), 6476. https://doi.org/10.3390/ijms24076476
Vancouver
Roh S, Kim S, Hong I, Lee M, Kim HJ, Ahn TS, et al. High Expression of Tetraspanin 5 as a Prognostic Marker of Colorectal Cancer. International Journal of Molecular Sciences. 2023;24(7):6476. doi:10.3390/ijms24076476
BibTeX
@article{Roh2023,
author = {Roh, Sanghyun and Kim, Sooyoun and Hong, Inpyo and Lee, Minho and Kim, Han Jo and Ahn, Tae Sung and Kang, Dong Hyun and Baek, Moo-Jun and Kwak, Hyoung Jong and Kim, Chang-Jin and Jeong, Dongjun},
title = {High Expression of Tetraspanin 5 as a Prognostic Marker of Colorectal Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {7},
pages = {6476},
doi = {10.3390/ijms24076476}
}
EUVIMED